@misc{indiciae0e93160c64da,
  title = {Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatment.},
  author = {Tracy B Bramlette and David H Lawson and Carl V Washington and Emir Veledar and Barry R Johns and Stacey F Brisman and Liana Abramova and Suephy C Chen},
  year = {2007},
  doi = {10.1111/j.1524-4725.2007.33001.x},
  url = {https://pubmed.ncbi.nlm.nih.gov/17214673/},
  note = {Source identifier: 17214673}
}